FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Publications
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News
✕

Honorary professorship for Prof. Heindl

HEINDL FOR 2240

HEINDL FOR 2240

Zhejiang University, School of Medicine in Hangzhou, China has awarded Prof. Dr. Dr. Ludwig M. Heindl, Department of Ophthalmology at the University Hospital Cologne and member of FOR 2240, with the dignity of Honorary Professor. The Senate of Zhejiang University selected Prof. Heindl for this special and rare honor based on his exceptional contributions to ophthalmology, especially in the field of ophthalmic oncology and ophthalmoplastic surgery.

“The title of Honorary Professor expresses a special appreciation in China that is given to very few hand-picked, outstanding scientists,” said Prof. Yao Ke, director of the Eye Center at the Second Affiliated Hospital of Zhejiang University, School of Medicine in Hangzhou. The Zhejiang University Eye Hospital is among the top 5 eye hospitals in China in terms of expertise. It is also considered one of the largest ophthalmology clinics in the world, with more than 550 employees, 28 operating rooms and 200 beds, with more than 80,000 surgeries and more than 800,000 outpatient visits annually. Prof. Heindl expressed his gratitude for this great honor and special distinction: “Our Chinese-German cooperation in ophthalmology is shaping up very successfully and we are very much looking forward to further joint scientific and clinical projects that will benefit patients with tumors on and in the eye.”

Prof. Heindl is Head of Ophthalmologic Oncology and Ophthalmoplastic Surgery at the Department of Ophthalmology at the University Hospital Cologne. Clinically and scientifically, he deals with tumors on and in the eye and specializes in the treatment of diseases of the eyelids, lacrimal ducts, orbits and ocular surface. He is part of the DFG-funded research group FOR 2240 and author of more than 300 peer-reviewed publications in the world’s most prestigious journals.

Related posts

January 7, 2023

Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface


Read more
December 15, 2022

Leonhard Klein-Preis for Prof. Matthaei


Read more
November 22, 2022

4th Shanghai-Cologne Scientific Symposium


Read more

News

  • Rare eye diseases: Eight million euros for research: Funding for four years
  • Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface
  • Experimental Glaucoma Research Group awarded and funded
  • Leonhard Klein-Preis for Prof. Matthaei
  • 4th Shanghai-Cologne Scientific Symposium

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Claudia Bock
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
claudia.bock@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck